| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |